Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2008137.pdf
Reference47 articles.
1. Berven LA, Willard FS, Crouch MF . (2004). Role of the p70S6K pathway in regulating the actin cytoskeleton and cell migration. Exp Cell Res 296: 183–195.
2. Boffa DJ, Luan F, Thomas D, Yang H, Sharma VK, Lagman M et al. (2004). Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res 10: 293–300.
3. Casamassima A, Rozengurt E . (1998). Insulin-like growth factor I stimulates tyrosine phosphorylation of p130Cas, focal adhesion kinase, and paxillin. Role of phosphatidylinositol 3′-kinase and formation of a p130Cas Crk complex. J Biol Chem 273: 26149–26156.
4. Erbay E, Chen J . (2001). The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J Biol Chem 276: 36079–36082.
5. Fonseca BD, Smith EM, Lee VH, Mackintosh C, Proud CG . (2007). PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J Biol Chem 282: 24514–24524.
Cited by 135 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of Akt/Protein Kinase B in Cancer Metastasis;Biomedicines;2023-11-08
2. Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer;Veterinary Pathology;2023-10-31
3. The HACE1 E3 ligase mediates RAC1‐dependent control of mTOR signaling complexes;EMBO reports;2023-10-17
4. PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells;Cell Communication and Signaling;2023-08-14
5. Expression of Ribosomal Protein S6 Kinase (S6K1) Isoforms in Different Types of Papillary Thyroid Carcinoma;Cytology and Genetics;2023-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3